Immortal Dragons
Overview
Immortal Dragons is a purpose-driven longevity fund headquartered in Singapore that invests in radical life extension technologies. The firm prioritizes impact over financial returns and focuses on areas including replacement and regeneration, gene therapy, and 3D bioprinting. It operates with a flexible single-LP structure, similar to a corporate venture capital fund.
Portfolio Companies
5
Website
id.lifeInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Kangaroo Biomedical | - | Seed | Co-investor |
| Etheros Pharmaceuticals | Dec 2025 | VC Round | Lead |
| Frontier Bio | Aug 2025 | Seed | Lead |
| R3 Bio | - | Seed | Co-investor |
| Unlimited Bio | Oct 2025 | Strategic | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Immortal Dragons based?
Immortal Dragons is headquartered in Singapore, Central Singapore, Singapore.
When was Immortal Dragons founded?
Founding year information for Immortal Dragons is not publicly available.
How many portfolio companies does Immortal Dragons have?
Immortal Dragons has 5 portfolio companies in Caplight's dataset.
What are some companies in Immortal Dragons's portfolio?
Portfolio companies visible on Caplight include Kangaroo Biomedical, Etheros Pharmaceuticals, Frontier Bio, R3 Bio, Unlimited Bio.
What was Immortal Dragons's most recent investment shown here?
Immortal Dragons's most recent investment in this portfolio sample was in Etheros Pharmaceuticals in 2025.
What sectors does Immortal Dragons focus on?
Immortal Dragons focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Immortal Dragons focus on?
Stage focus information for Immortal Dragons is not publicly available.
What is Immortal Dragons's AUM?
Immortal Dragons's assets under management are estimated between $40.0M and $40.0M.